Epirus

Multiple Leonidas systems delivered to U.S. Army under IFPC-HPM with NET and EDT completed, followed by a $43.5M Gen II award in Aug 2025 — demonstrating sustained government progression beyond prototyping

Demonstrated defeat of a 49-drone swarm (100% kill rate) and fiber-optic-controlled UAS, addressing emerging hardened drone threats that conventional RF jamming cannot counter

Product family expansion into maritime (Leonidas H2O), expeditionary (with ONR/JCO/USMC), and compact EW (Leonidas Pod) broadens addressable market across all military domains

Deep ecosystem partnerships with Anduril, GDLS, Peraton, L3Harris, and Palantir embed Leonidas into layered kill chains and autonomous platforms, reducing adoption friction

$595M in total funding including $250M Series D in March 2025 specifically earmarked to 'hyperscale' production, providing substantial runway for manufacturing scale-up

Early international traction via DSTA partnership (Feb 2026) signals potential export diversification beyond concentrated U.S. DoD customer base

No formal program-of-record status disclosed for IFPC-HPM; all Army activity remains in prototyping/developmental phases, and budget shifts or competing solutions could stall procurement

Revenue, gross margins, backlog, and unit economics are entirely undisclosed — investors have no visibility into whether the business model is economically viable at scale

Frequent C-suite turnover (multiple CEO changes, new CTO and CFO in 2025) may indicate strategic instability or execution challenges during a critical scaling phase

HPM performance claims (49-drone swarm defeat) are company-reported without independent third-party validation details on test conditions, environments, or target diversity

Maritime and expeditionary variants (H2O, Expeditionary) are early-stage with unproven operational durability in corrosive saltwater, adverse weather, and complex EMI environments

cUAS budgets are split across competing modalities (lasers, kinetic interceptors, RF takeover, radar/EO) — Epirus must continuously justify its cost-per-engagement advantage against alternatives

IFPC-HPM may not convert to a formal program of record, leaving Epirus dependent on episodic prototype and R&D contracts rather than stable multi-year procurement

HPM export controls could severely constrain international sales, limiting revenue diversification beyond concentrated U.S. DoD dependency

Manufacturing scale-up from low-rate prototype deliveries to production volumes is unproven and capital-intensive, with no disclosed production yield or capacity data

Competing cUAS modalities (high-energy lasers from Lockheed/RTX, kinetic interceptors, RF takeover from D-Fend) may capture larger budget shares in layered defense architectures

Operational performance in degraded environments (maritime corrosion, urban EMI clutter, adverse weather) remains unvalidated in disclosed materials

Burn rate on $595M in venture funding with opaque revenue creates potential future dilution or down-round risk if procurement timelines slip

U.S. Army IFPC-HPM Gen II milestone completion and any announcement of formal program-of-record status or full-rate production decision

U.S. Navy/USMC operational test results for ExDECS and Leonidas H2O maritime variants, validating HPM effectiveness in naval environments

First international procurement contract following the DSTA partnership, signaling export viability and revenue diversification

Independent third-party validation of swarm defeat performance metrics under operationally realistic conditions

Palantir Warp Speed manufacturing acceleration outcomes demonstrating production scalability and delivery cadence improvement